Abbott Laboratories
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Abbott Laboratories generated cash of $7,261,000,000, which is less than the previous year. Cash used in financing activities reached the amount of -$7,091,000,000 last year. Net change in cash is therefore -$2,986,000,000.
Cash Flow
| 2014 | 3.67B | -202M | -2.74B |
|---|---|---|---|
| 2015 | 2.96B | 406M | -2.23B |
| 2016 | 3.20B | -248M | 11.14B |
| 2017 | 5.57B | -9.61B | -5.28B |
| 2018 | 6.3B | -1.35B | -10.39B |
| 2019 | 6.13B | -1.81B | -4.28B |
| 2020 | 7.90B | -2.21B | -2.77B |
| 2021 | 10.53B | -2.00B | -5.49B |
| 2022 | 9.58B | -1.74B | -7.63B |
| 2023 | 7.26B | -3.13B | -7.09B |
ABT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 9.88B | 9.79B | 6.83B | 3.86B | 3.84B | 9.40B | 18.62B | 5.00B | 4.06B | 3.47B |
Operating activities | ||||||||||
Net income | 5.72B | 6.93B | 7.07B | 4.49B | 3.68B | 2.36B | 477M | 1.37B | 1.58B | 2.28B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.24B | 3.26B | 3.53B | 3.32B | 3.01B | 3.27B | 3.02B | 1.35B | 1.47B | 1.54B |
Stock-based compensation expense | 644M | 685M | 640M | 546M | 519M | 477M | 406M | 310M | 292M | 246M |
| Deferred income tax benefit | 644M | 685M | 640M | 546M | 519M | 477M | 406M | 310M | 292M | 246M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -356M | -68M | -383M | -924M | -275M | -190M | -207M | -177M | -171M | -195M |
Inventories | -232M | -1.41B | -456M | -493M | -593M | -514M | 249M | -98M | -257M | -297M |
Accounts payable | -760M | 420M | 1.28B | 1.76B | 220M | 747M | 615M | -652M | -742M | -225M |
Cash generated by operating activities | 7.26B | 9.58B | 10.53B | 7.90B | 6.13B | 6.3B | 5.57B | 3.20B | 2.96B | 3.67B |
Investing activities | ||||||||||
Purchases Of Investments | -159M | -185M | -173M | -83M | -103M | -131M | -210M | -2.82B | -4.93B | -1.50B |
Investments In Property Plant And Equipment | -2.20B | -1.77B | -1.88B | -2.17B | -1.63B | -1.39B | -1.13B | -1.12B | -1.11B | -1.07B |
Acquisitions Net | -837M | 48M | -53M | 16M | -122M | 48M | -8.43B | -55M | 2.28B | -3.31B |
Cash generated by investing activities | -3.13B | -1.74B | -2.00B | -2.21B | -1.81B | -1.35B | -9.61B | -248M | 406M | -202M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 255M | 1.52B | 0 | 271M | 0 | 13.41B | 0 | 1.77B |
Payments for dividends | -3.55B | -3.30B | -3.20B | -2.56B | -2.27B | -1.97B | -1.84B | -1.53B | -1.44B | -1.34B |
Repurchases of common stock | -1.22B | -3.79B | -2.29B | -403M | -718M | -238M | -827M | -522M | -2.23B | -2.19B |
Repayments of term debt | -2.47B | -699M | -48M | -1.33B | -1.59B | -12.43B | -1.90B | -12M | 1.14B | -577M |
Cash used in financing activities | -7.09B | -7.63B | -5.49B | -2.77B | -4.28B | -10.39B | -5.28B | 11.14B | -2.23B | -2.74B |
Net Change In Cash | -2.98B | 83M | 2.96B | 2.97B | 16M | -5.56B | -9.21B | 13.61B | 938M | 588M |
Cash at end of period | 6.89B | 9.88B | 9.79B | 6.83B | 3.86B | 3.84B | 9.40B | 18.62B | 5.00B | 4.06B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |